Daniel Perry

Dan specialises in Children’s Hip Disease (Perthes’ Disease, Hip Dysplasia and Slipped Epiphysis), Bone Cysts and Trauma. He trained in Liverpool and Warwick, before completing a children’s orthopaedic fellowship at SickKids Hospital, Toronto, Canada. He is the first orthopaedic surgeon to have been awarded a prestigious NIHR Research Professorship.

Dan’s major research interests are in epidemiology and effectiveness research. He has an international portfolio of clinical trials. He has over >£30m (USD $35 million) in research income, including being chief investigator on the NIHR British Orthopaedic Surgery Surveillance (BOSS) Study (Paediatric Hip Disease), the NIHR FORCE Study (Simple Wrist Fractures) and the NIHR SCIENCE Study (Medial Epicondyle Fractures), the NIHR CRAFFT Study (Severe Wrist Fractures), the NIHR BigBOSS Study (Hip Disease), the NIHR BASIS Study (Scoliosis) and the NIHR Odd SOCKS Study (Ankle Fractures). He is currently working Lurie Children’s Hospital in Chicago (USA) to reproduce the UK studies throughout North America, with an NIH R01 grant recently awarded.

Dan supervises several PhD students, and oversees a broad team within the clinical trials unit of biostatisticians, health economists, trial managers and data specialists.

He is a member of the NIHR HTA Commissioning Board and Associate Editor of the Bone and Joint Journal. He also sits on the research committee of the British Orthopaedic Association (BOA) and the research committee of BSCOS (British Society for Children's Orthopaedic Surgery).